Magnetar Financial LLC Heron Therapeutics, Inc. Transaction History

Magnetar Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $421,514 - $1.15 Million	-183,267 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $84,228 - $180,828	18,192 Added 11.02%	183,267 $1.05 Million
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $59,393 - $89,623	7,113 Added 4.5%	165,075 $1.51 Million
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $1.6 Million - $2.37 Million	157,962 New	157,962 $1.69 Million

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.